One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
In Vitro Diagnostic Design: What are LDT and IVD?April 4, 2023Medical professionals usually rely on various tools to diagnose conditions and guide treatment decisions. The most commonly used is in vitro diagnostics (IVD) technology. Patients may receive or decli...view
What Are Microfluidic Platforms?November 10, 2023Microfluidic platforms are a powerful and innovative technology that is revolutionizing a wide range of industries. These platforms are designed to handle and process small amounts of fluids, often on...view
Prostate Cancer (PCA) Is A Difficult Disease To UnderstandJune 28, 2022Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-t...view
Concept and Application of Microarray PlatformsApril 16, 2025Concept of Microarray PlatformsA microarray platform is a high-throughput experimental platform based on miniaturization technology. It can simultaneously detect and analyze multiple biomolecules (suc...view